MedTrace Logo

SAGIT for Classification of Patients With Acromegaly in Clinical Practice

NCT02231593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2020-03-31

No results posted yet for this study

Summary

The purpose of this pilot study is to test SAGIT (Signs and symptoms - Associated comorbidities - GH concentration level - IGF-1 - Tumour). SAGIT is a Clinician-Reported Outcomes (ClinROs) tool developed to describe patients with acromegaly. This study will determine the potential use of a finalised operational version for patient classification in clinical practice and studies.

In addition, this study intends to carry out a qualitative evaluation of the acceptability of SAGIT by the practicing endocrinologist in terms of relevance, ease of use, applicability and usefulness of the tool in practice.

Conditions

Interventions

OTHER

SAGIT

SAGIT is a Clinician-Reported Outcomes (ClinROs) tool

Sponsors & Collaborators

Principal Investigators

  • Ipsen Study Director · Ipsen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States
  • Brazil
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02231593 on ClinicalTrials.gov